Key facts
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for Immix Biopharma, Inc. Common Stock, par value $0.0001 per share (IMMX).
- Disclosed ownership: 3.3%.
- Date of event: 31 Mar 2026.
MILLENNIUM MANAGEMENT LLC - 31 Mar 2026 SCHEDULE 13G/A Report for Immix Biopharma, Inc. Common Stock, par value $0.0001 per share (IMMX)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- IMMX
- Shares outstanding
- 53,036,364 shares
- Disclosed Ownership
- 1,750,200 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 04 May 2026, 16:30:39 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 20 Mar 2026
- SEC
- View on sec.gov
Key filing fact
MILLENNIUM MANAGEMENT LLC disclosed 3.3% ownership in Immix Biopharma, Inc. Common Stock, par value $0.0001 per share (IMMX) on 31 Mar 2026.
Change
- Previous schedule filing date: 20 Mar 2026.
- Current filing was accepted on 04 May 2026, 16:30.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Millennium Management LLC | 3.3% | 1,750,200 | 0 | 1,750,200 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 3.3% | 1,750,200 | 0 | 1,750,200 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 3.3% | 1,750,200 | 0 | 1,750,200 | /s/ Israel A. Englander | Israel A. Englander |
CIK / CUSIP context first